Review of Various Approaches to Alzheimer's Disease Treatment Have Focused Solely on ß-Secretase (BACE) As A Ligand’s Target in the Last Two Decades - Egyptian Knowledge Bank - troweb

424768

Review of Various Approaches to Alzheimer's Disease Treatment Have Focused Solely on ß-Secretase (BACE) As A Ligand’s Target in the Last Two Decades

Article

Last updated: 04 May 2025

Overview Similar Items

Article

Recent insight into BACE1 as a potential target for treatment of Alzheimer's disease

Article

Efficacy of Beta-Secretase-1 Enzyme Inhibitors in Alzheimer's Disease

Article

Acetylcholine Esterase Inhibition in Alzheimer's Therapy: Spotlight on Quinzolinone Derivatives

Article

Unrevealing therapeutic strategies in Chemicals-induced Sporadic Alzheimer's Disease

Article

Innovations in acetylcholinesterase inhibitors: emerging strategies for Alzheimer’s disease therapy (2019–2024)

Article

A Promising Approach for the Treatment of Experimental Alzheimer's disease: Impact of Cardamom Essential Oil

Article

Design, Synthesis, Molecular Docking and Biological Evaluation of Donepezil Analogues as Effective Anti-Alzheimer Agents.

Article

Molecular Docking of Pepstatin (A) and Compounds with Structural Similarity to the Molecular Model of Human BACE-1 Enzyme

Article

Role of Dasatinb in Alzheimer's Disease: Review Article

Article

cAMP/PKA-CREB-BDNF Signaling Cascade and Phosphodiesterase 4 Inhibition: A ‎Possible Neuroprotective Approach in Alzheimer’s Disease